Abbott Laboratories Current Cash

Abbott Laboratories (ABT) currently reports a current cash of $5.1B as of June 2026. That compares with $7B in the prior-year period — down 26.6% year over year. Use the charts on this page to explore Abbott Laboratories's current cash history and peer comparisons.

Abbott Laboratories's current cash decreased from $7B to $5.1B — a 26.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Abbott Laboratories reported $5.1B in current cash as of June 2026. That compares with $7B in the prior-year period — down 26.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $5.1B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Abbott Laboratories, and consider following ABT for alerts when major investors trade the stock.

Abbott Laboratories is classified in the Healthcare sector. On current cash, it currently shows $5.1B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ABT with unrelated industries.